Baddeley, 2003, Working memory: looking back and looking forward, Nat. Rev. Neurosci., 4, 829, 10.1038/nrn1201
Bearden, 2016, A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I, Ann. Clin. Transl. Neurol., 3, 266, 10.1002/acn3.288
Billingsley, 2004, Functional MRI of visual–spatial processing in neurofibromatosis, type I, Neuropsychologia, 42, 395, 10.1016/j.neuropsychologia.2003.07.008
Broyd, 2009, Default-mode brain dysfunction in mental disorders: a systematic review, Neurosci. Biobehav. Rev., 33, 279, 10.1016/j.neubiorev.2008.09.002
Buckner, 2008, The brain's default network, Ann. N. Y. Acad. Sci., 1124, 1, 10.1196/annals.1440.011
Cawthon, 1990, A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations, Cell, 62, 193, 10.1016/0092-8674(90)90253-B
Clements-Stephens, 2008, Visuospatial processing in children with neurofibromatosis type 1, Neuropsychologia, 46, 690, 10.1016/j.neuropsychologia.2007.09.013
Costa, 2002, Review article: molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1, J. Child Neurol., 17, 622, 10.1177/088307380201700813
Costa, 2002, Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1, Nature, 415, 526, 10.1038/nature711
Eklund, 2016, Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates, Proc. Natl. Acad. Sci. U. S. A., 113, 7900, 10.1073/pnas.1602413113
Fain, 1987, Genetic analysis of NF1: identification of close flanking markers on chromosome 17, Genomics, 1, 340, 10.1016/0888-7543(87)90034-6
Garg, 2013, Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study, Dev. Med. Child Neurol., 55, 139, 10.1111/dmcn.12043
Glahn, 2002, Maintenance and manipulation in spatial working memory: dissociations in the prefrontal cortex, NeuroImage, 17, 201, 10.1006/nimg.2002.1161
Gold, 1997, Auditory working memory and Wisconsin card sorting test performance in schizophrenia, Arch. Gen. Psychiatry, 54, 159, 10.1001/archpsyc.1997.01830140071013
Hyman, 2005, The nature and frequency of cognitive deficits in children with neurofibromatosis type 1, Neurology, 65, 1037, 10.1212/01.wnl.0000179303.72345.ce
Hyman, 2006, Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit–hyperactivity disorder, Dev. Med. Child Neurol., 48, 973, 10.1017/S0012162206002131
Jenkinson, 2001, A global optimisation method for robust affine registration of brain images, Med. Image Anal., 5, 143, 10.1016/S1361-8415(01)00036-6
Karlsgodt, 2012, Alterations in white matter microstructure in neurofibromatosis-1, PLoS One, 7, 10.1371/journal.pone.0047854
Levine, 2006, Cognitive profile of neurofibromatosis type 1, Semin. Pediatr. Neurol., 13, 8, 10.1016/j.spen.2006.01.006
Mainberger, 2013, Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1, BMC Neurol., 13, 131, 10.1186/1471-2377-13-131
McLaren, 2012, A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approaches, NeuroImage, 61, 1277, 10.1016/j.neuroimage.2012.03.068
Montojo, 2014, Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome, NeuroImage Clin., 4, 392, 10.1016/j.nicl.2014.01.010
Moore, 2000, Brain volume in children with neurofibromatosis type 1 relation to neuropsychological status, Neurology, 54, 914, 10.1212/WNL.54.4.914
North, 2000, Neurofibromatosis type 1, Am. J. Med. Genet., 97, 119, 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3
Payne, 2010, Brain structure and function in neurofibromatosis type 1: current concepts and future directions, J. Neurol. Neurosurg. Psychiatry, 81, 304, 10.1136/jnnp.2009.179630
Payne, 2011, Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior, Child Neuropsychol., 17, 313, 10.1080/09297049.2010.542746
Payne, 2016, Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1, Neurology, 87, 2575, 10.1212/WNL.0000000000003435
Poldrack, 2016, A phenome-wide examination of neural and cognitive function, Sci. Data, 10.1038/sdata.2016.110
Poldrack, 2016, A phenome-wide examination of neural and cognitive function, 59733
Rowbotham, 2009, Cognitive control in adolescents with neurofibromatosis type 1, Neuropsychology, 23, 50, 10.1037/a0013927
Roy, 2010, Executive dysfunction in children with neurofibromatosis type 1: a study of action planning, J. Int. Neuropsychol. Soc., 16, 1056, 10.1017/S135561771000086X
Shilyansky, 2010, Neurofibromin regulates corticostriatal inhibitory networks during working memory performance, Proc. Natl. Acad. Sci., 107, 13141, 10.1073/pnas.1004829107
Smith, 2004, Advances in functional and structural MR image analysis and implementation as FSL, NeuroImage, 23, S208, 10.1016/j.neuroimage.2004.07.051
Stumf, 1988, NIH consensus development conference. Neurofibromatosis conference statement, Arch. Neurol., 45, 575, 10.1001/archneur.1988.00520290115023
Todd, 2004, Capacity limit of visual short-term memory in human posterior parietal cortex, Nature, 428, 751, 10.1038/nature02466
Tomson, 2015, Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1, Hum. Brain Mapp., 36, 4566, 10.1002/hbm.22937
Violante, 2012, Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network, PLoS One, 7, 10.1371/journal.pone.0038785
Viskochil, 1990, Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus, Cell, 62, 187, 10.1016/0092-8674(90)90252-A
Wallace, 1990, Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients, Science, 249, 181, 10.1126/science.2134734
Wechsler, 2011
Wechsler, 2014